Streptomycin Injectable Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV/IM)
Available Strengths: 1 g/2 mL, 2 g/2 mL
Reference Brands: Generic formulations marketed under different names
Category:
Antibiotics
Streptomycin inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, causing improper protein formation and bacterial death. It is effective against tuberculosis and severe bacterial infections. Benefits include rapid bactericidal activity, high efficacy against multidrug-resistant bacteria, and use in critical care settings when administered properly.
Streptomycin injectable is available in Injectable (IV/IM)
and strengths such as 1 g/2 mL, 2 g/2 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Streptomycin injectable is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Streptomycin injectable can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Streptomycin injectable is approved in the EU and US for treating tuberculosis and serious bacterial infections. In the EU, brands are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval depends on comprehensive clinical data, with generic formulations available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans for approval and ongoing safety monitoring. Due to its critical role in combating MDR bacteria, strict prescribing controls and safety protocols are enforced. For regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access consistent with European and US standards for safe, effective antibiotic therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing